Since PERK/ATF4 signaling mediated DHA-induced UPR in glioma cells, we investigated whether PERK/ATF4 inhibition enhanced anticancer activity of DHA through ferroptosis induction. This evidence concerns the gene ATF4 and central nervous system cancer.